J‐M Verdebout

985 total citations
11 papers, 792 citations indexed

About

J‐M Verdebout is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J‐M Verdebout has authored 11 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in J‐M Verdebout's work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). J‐M Verdebout is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). J‐M Verdebout collaborates with scholars based in Belgium, France and Luxembourg. J‐M Verdebout's co-authors include Sculier Jp, A-P Meert, J.J. Lafitte, P. Delmotte, Céline Mascaux, Elizabeth Steels, Bradley C. Martin, C. Mascaux, Thierry Berghmans and M Paesmans and has published in prestigious journals such as Gut, British Journal of Cancer and European Respiratory Journal.

In The Last Decade

J‐M Verdebout

11 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J‐M Verdebout Belgium 10 430 413 316 125 82 11 792
F. De Vita Italy 11 405 0.9× 196 0.5× 198 0.6× 220 1.8× 85 1.0× 37 691
Sabrina Vari Italy 13 272 0.6× 186 0.5× 435 1.4× 196 1.6× 60 0.7× 30 800
Woo Sun Kwon South Korea 16 401 0.9× 271 0.7× 267 0.8× 128 1.0× 57 0.7× 51 677
Minaxi Jhawer United States 11 484 1.1× 383 0.9× 305 1.0× 98 0.8× 34 0.4× 14 842
Toshio Fujino Japan 16 420 1.0× 563 1.4× 402 1.3× 142 1.1× 72 0.9× 54 975
Xiao‐Dong Jiao China 17 383 0.9× 338 0.8× 291 0.9× 213 1.7× 30 0.4× 56 821
M. Ebert Germany 11 328 0.8× 271 0.7× 240 0.8× 189 1.5× 109 1.3× 17 732
Qiang Zuo China 13 315 0.7× 133 0.3× 417 1.3× 200 1.6× 57 0.7× 39 805
Maria Rosa Cappelletti Italy 13 312 0.7× 251 0.6× 213 0.7× 239 1.9× 57 0.7× 32 635

Countries citing papers authored by J‐M Verdebout

Since Specialization
Citations

This map shows the geographic impact of J‐M Verdebout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J‐M Verdebout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J‐M Verdebout more than expected).

Fields of papers citing papers by J‐M Verdebout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J‐M Verdebout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J‐M Verdebout. The network helps show where J‐M Verdebout may publish in the future.

Co-authorship network of co-authors of J‐M Verdebout

This figure shows the co-authorship network connecting the top 25 collaborators of J‐M Verdebout. A scholar is included among the top collaborators of J‐M Verdebout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J‐M Verdebout. J‐M Verdebout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Verdebout, J‐M, et al.. (2010). IMMUNE THROMBOCYTOPENIC PURPURA AT THE DIAGNOSIS OF HODGKIN DISEASE. Acta Clinica Belgica. 65(1). 41–43. 1 indexed citations
3.
Mascaux, Céline, et al.. (2005). COX-2 expression during early lung squamous cell carcinoma oncogenesis. European Respiratory Journal. 26(2). 198–203. 19 indexed citations
4.
Feoli, Francesco, Bradley C. Martin, J‐M Verdebout, et al.. (2004). Ki67 expression in bronchial preneoplastic lesions and carcinoma in situ defined according to the new 1999 WHO/IASLC criteria: a preliminary study. Histopathology. 44(1). 47–53. 17 indexed citations
5.
Meert, A-P, J‐M Verdebout, Bradley C. Martin, et al.. (2003). Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions. European Respiratory Journal. 21(4). 611–615. 25 indexed citations
6.
Martin, Bénédicte, M Paesmans, C. Mascaux, et al.. (2003). The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature. British Journal of Cancer. 89(6). 959–965. 86 indexed citations
7.
Martin, Bradley C., J‐M Verdebout, M Paesmans, et al.. (2003). [EGF-R expression correlation between biopsy and surgical specimens of lung carcinoma].. PubMed. 20(3 Pt 1). 347–53. 9 indexed citations
8.
Martin, Benoı̂t, M Paesmans, Thierry Berghmans, et al.. (2003). Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis. British Journal of Cancer. 89(1). 55–64. 130 indexed citations
9.
Meert, A-P, M Paesmans, Benjamín Martín, et al.. (2002). The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. British Journal of Cancer. 87(7). 694–701. 193 indexed citations
10.
Meert, A-P, Bradley C. Martin, P. Delmotte, et al.. (2002). The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. European Respiratory Journal. 20(4). 975–981. 230 indexed citations
11.
Martin, Bradley C., J‐M Verdebout, Céline Mascaux, et al.. (2002). Expression of p53 in preneoplastic and early neoplastic bronchial lesions. Oncology Reports. 9(2). 223–9. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026